Voya Investment Management LLC Next Cure, Inc. Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.6 - $10.28 $3.41 Million - $4.62 Million	-449,208 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.81 - $13.88 $745,638 - $1.05 Million	-76,008 Reduced 14.47%	449,208 $4.5 Million
Q4 2020 Feb 16, 2021	SELL	$9.47 - $12.43 $452,097 - $593,408	-47,740 Reduced 8.33%	525,216 $5.72 Million
Q3 2020 Nov 16, 2020	BUY	$8.15 - $21.17 $2.06 Million - $5.35 Million	252,937 Added 79.04%	572,956 $5.04 Million
Q2 2020 Aug 14, 2020	BUY	$21.19 - $40.2 $5.96 Million - $11.3 Million	281,204 Added 724.47%	320,019 $6.86 Million
Q1 2020 May 15, 2020	BUY	$32.32 - $58.37 $1.03 Million - $1.86 Million	31,896 Added 460.99%	38,815 $1.44 Million
Q4 2019 Feb 14, 2020	BUY	$25.0 - $92.22 $172,975 - $638,070	6,919 New	6,919 $390,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.